Filter
607
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
52
New Publications
198
Language
Document type
No document type
335
Studies & Reports
104
Guidelines
88
Manuals
34
Strategic & Response Plan
26
Fact sheets
8
Situation Updates
5
Training Material
4
Resource Platforms
2
Brochures
1
Countries / Regions
Kenya
36
Ethiopia
31
India
25
Uganda
24
South Africa
20
Ghana
17
Tanzania
17
Liberia
16
Rwanda
16
Nigeria
15
Zambia
15
Malawi
13
Nepal
11
Sierra Leone
10
Zimbabwe
10
Western and Central Europe
10
Bangladesh
9
Namibia
8
Ukraine
8
Myanmar / Burma
8
Lesotho
7
Global
7
Eastern Europe
6
Philippines
5
Indonesia
5
Eswatini/ Swaziland
5
Botswana
5
Syria
4
Cambodia
4
Benin
3
Albania
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
Cameroon
2
Haiti
2
Pakistan
2
Jordan
2
Thailand
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Africa
2
Laos
2
USA
1
Somalia
1
Afghanistan
1
Germany
1
Chad
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
East and Southern Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Fiji
1
Timor Leste/ East Timor
1
Moldova
1
Australia
1
Vietnam
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
325
Clinical Guidelines
33
Pharmacy & Technologies
19
Key Resources
17
Public Health
9
Women & Child Health
8
Capacity Building
3
Toolboxes
Pharmacy
88
AMR
81
COVID-19
30
TB
23
Rapid Response
22
HIV
19
Mental Health
17
Global Health Education
9
Ebola
6
Conflict
6
Planetary Health
6
Health Financing Toolbox
5
NCDs
4
Specific Hazards
3
Caregiver
3
NTDs
3
Polio
2
Refugee
2
Natural Hazards
1
Zika
1
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the pop
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically
...
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Extract from "Essentials of Pharmaceutical Practice - EPP Handbook" by Ecumenical Pharmaceutical Network (EPN) (ISBN 978-9966-094-44-5). Chapter contents: Definition and understanding about SOPs -
...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory
...
Rwanda: FEES FOR REGISTRATION OF PHARMACEUTICAL PRODUCTS, MEDICAL DEVICES AND OTHER RELATED SERVICES
MINISTERIAL ORDER Nº 002/17/10/TC OF 27/10/2017 DETERMINING THE FEES FOR REGISTRATION OF PHARMACEUTICAL PRODUCTS, MEDICAL DEVICES AND OTHER RELATED SERVICES | Official Gazette nº 46 of 13/11/2017
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
